Page last updated: 2024-09-04

nps-568 and Atherosclerosis

nps-568 has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caudrillier, A; Drüeke, TB; Fukagawa, M; Hamada, Y; Ivanovski, O; Joki, N; Kamel, S; Lacour, B; Maizel, J; Massy, ZA; Mentaverri, R; Nguyen-Khoa, T; Nikolov, IG; Phan, O	1

Other Studies

1 other study(ies) available for nps-568 and Atherosclerosis

Article	Year
The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis, 2009, Volume: 205, Issue:1 Topics: Aniline Compounds; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Calcinosis; Calcium; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Kidney Failure, Chronic; Mice; Mice, Transgenic; Phenethylamines; Phosphorus; Propylamines; Receptors, Calcium-Sensing; Uremia	2009

Article

Year

The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.

Atherosclerosis, 2009, Volume: 205, Issue:1

Topics: Aniline Compounds; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Calcinosis; Calcium; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Kidney Failure, Chronic; Mice; Mice, Transgenic; Phenethylamines; Phosphorus; Propylamines; Receptors, Calcium-Sensing; Uremia

2009